COAGULATION DISORDERS IN CANCER
Authors:
- Harvey R. GralnickHGHarvey R. Gralnick
- 1 April 1996
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 10 (2) , 457-484
Abstract
No abstract availableKeywords
This publication has 248 references indexed in Scilit:
- Hemostatic alterations in cancer patientsCancer and Metastasis Reviews, 1992
- Identification and partial purification of a novel tumor-derived protein that induces tissue factor on cultured human endothelial cellsBiochemical and Biophysical Research Communications, 1989
- Acquired von Willebrand’s Syndrome Due to an Inhibitor of IgG Specific for von Willebrand’s Factor in Polycythemia rubra veraActa Haematologica, 1987
- Multiple myeloma with polyneuropathy and coagulopathy. A case report of the polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin change (POEMS) syndromeArchives of internal medicine (1960), 1986
- Circulating Heparan Sulfate Anticoagulant in a Patient with a Fatal Bleeding DisorderNew England Journal of Medicine, 1984
- Mechanism of Factor X Deficiency in Systemic AmyloidosisNew England Journal of Medicine, 1981
- Factor X Deficiency in Primary AmyloidosisNew England Journal of Medicine, 1979
- Elevated Platelet-Associated IgG in the Thrombocytopenia of SepticemiaNew England Journal of Medicine, 1979
- A Hemorrhagic Syndrome in Waldenström's Macroglobulinemia Secondary to Immunoadsorption of Factor VIIINew England Journal of Medicine, 1979
- Syndrome of Acquired Factor X Deficiency and Systemic AmyloidosisNew England Journal of Medicine, 1977